Buys
Open market- Shares
- Avg price
- Total value
Frank Torti - President and Vant Chair at Roivant Sciences Ltd.
Issuer-level insider activity
- Role
- President and Vant Chair
- Issuer ticker
- ROIV on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Frank Torti in Roivant Sciences Ltd.
Sells
Open market- Shares
- -3,000,000
- Avg price
- $27.35
- Total value
- -$82,039,460
Net
Past year- Shares
- -3,000,000
- Share %
- -100%
- Total value
- -$82,039,460
Reported holdings for Frank Torti in Roivant Sciences Ltd.
Form 4 holding
President and Vant Chair
Roivant Sciences Ltd.
- Security class
- Common Shares
- Shares / value
- 13,495,893
- Estimated value
- $477,619,653
- Report date
- 30 Sep 2026
- Price
- $35.39
- Ownership
- Direct
Form 4 holding
President and Vant Chair
Roivant Sciences Ltd.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 3,026,184
- Estimated value
- Report date
- 23 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Frank Torti in Roivant Sciences Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.